ARYLATION OF MGMT BY PARP IS REQUIRED FOR MGMT MEDIATED TEMOZOLOMIDE-INDUCED O6-METHYLGUANINE REPAIR: A NOVEL MECHANISM OF MGMT ACTION

被引：0
|
作者：
Wu, Shaofang [1 ]
Gao, Feng [1 ]
Koul, Dimpy [1 ]
Yung, Alfred [1 ]
机构：
[1] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
来源：
NEURO-ONCOLOGY | 2019年 / 21卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
DRES-02
引用
收藏
页码：71 / 72
页数：2
相关论文
共 50 条
  • [31] O6-methylguanine-DNA methyltransferase (MGMT): Can function explain a suicidal mechanism?
    Gouws, Chrisna
    Pretorius, Pieter J.
    MEDICAL HYPOTHESES, 2011, 77 (05) : 857 - 860
  • [32] O6-methylguanine-DNA methyltransferase (MGMT) immunohistochemistry as a predictor of resistance to temozolomide in primary CNS lymphoma
    Xiaoyin Jiang
    David A. Reardon
    Annick Desjardins
    James J. Vredenburgh
    Jennifer A. Quinn
    Alan D. Austin
    James E. Herndon
    Roger E. McLendon
    Henry S. Friedman
    Journal of Neuro-Oncology, 2013, 114 : 135 - 140
  • [33] O6-methylguanine-DNA methyltransferase (MGMT) immunohistochemistry as a predictor of resistance to temozolomide in primary CNS lymphoma
    Jiang, Xiaoyin
    Reardon, David A.
    Desjardins, Annick
    Vredenburgh, James J.
    Quinn, Jennifer A.
    Austin, Alan D.
    Herndon, James E., II
    McLendon, Roger E.
    Friedman, Henry S.
    JOURNAL OF NEURO-ONCOLOGY, 2013, 114 (01) : 135 - 140
  • [34] Low O6-methylguanine-DNA methyltransferase (MGMT) expression and response to temozolomide in aggressive pituitary tumours
    McCormack, Ann I.
    McDonald, Kerrie L.
    Gill, Anthony J.
    Clark, Susan J.
    Burt, Morton G.
    Campbell, Kirsten A.
    Braund, Wilton J.
    Little, Nicholas S.
    Cook, Raymond J.
    Grossman, Ashley B.
    Robinson, Bruce G.
    Clifton-Bligh, Roderick J.
    CLINICAL ENDOCRINOLOGY, 2009, 71 (02) : 226 - 233
  • [35] O6-Methylguanine-DNA Methytransferase (MGMT) Immunohistochemistry as a Predictor of Resistance to Temozolomide in Primary CNS Lymphoma
    Jiang, X.
    Reardon, D. A.
    Desjardins, A.
    Vredenburgh, J. J.
    Quinn, J. A.
    Austin, A. D.
    Herndon, J. E.
    McLendon, R. E.
    Friedman, H. S.
    LABORATORY INVESTIGATION, 2011, 91 : 382A - 382A
  • [36] CHROMATIN REMODELING-MEDIATED OVEREXPRESSION OF MGMT AS A NOVEL MECHANISM OF TEMOZOLOMIDE RESISTANCE IN GLIOBLASTOMA XENOGRAFTS
    Kitange, Gaspar J.
    Mladek, Ann C.
    Carlson, Brett
    Schroeder, Mark
    Sarkaria, Jann
    NEURO-ONCOLOGY, 2009, 11 (05) : 593 - 594
  • [37] Quantitative analysis of O6-methylguanine DNA methyltransferase (MGMT) promoter methylation in patients with low-grade gliomas
    Adrian F. Ochsenbein
    Adrian D. Schubert
    Erik Vassella
    Luigi Mariani
    Journal of Neuro-Oncology, 2011, 103 : 343 - 351
  • [38] Apoptosis in malignant glioma cells triggered by the temozolomide-induced DNA lesion O6-methylguanine
    W P Roos
    L F Z Batista
    S C Naumann
    W Wick
    M Weller
    C F M Menck
    B Kaina
    Oncogene, 2007, 26 : 186 - 197
  • [39] Comparison of single- versus double-bolus treatments of O6-benzylguanine for depletion of O6-methylguanine DNA methyltransferase (MGMT) activity in vivo:: Development of a novel fluorometric oligonucleotide assay for measurement of MGMT activity
    Kreklau, EL
    Liu, NL
    Li, ZH
    Cornetta, K
    Erickson, LC
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2001, 297 (02): : 524 - 530
  • [40] Quantitative analysis of O6-methylguanine DNA methyltransferase (MGMT) promoter methylation in patients with low-grade gliomas
    Ochsenbein, Adrian F.
    Schubert, Adrian D.
    Vassella, Erik
    Mariani, Luigi
    JOURNAL OF NEURO-ONCOLOGY, 2011, 103 (02) : 343 - 351
12345